FI973530L - Tetraliineja - Google Patents

Tetraliineja Download PDF

Info

Publication number
FI973530L
FI973530L FI973530A FI973530A FI973530L FI 973530 L FI973530 L FI 973530L FI 973530 A FI973530 A FI 973530A FI 973530 A FI973530 A FI 973530A FI 973530 L FI973530 L FI 973530L
Authority
FI
Finland
Prior art keywords
tetralin
Prior art date
Application number
FI973530A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI973530A7 (fi
FI973530A0 (fi
Inventor
Robert Swoboda
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774032&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI973530(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI973530A0 publication Critical patent/FI973530A0/fi
Publication of FI973530A7 publication Critical patent/FI973530A7/fi
Publication of FI973530L publication Critical patent/FI973530L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
FI973530A 1995-05-05 1996-05-03 Tetraliineja FI973530L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509156.7A GB9509156D0 (en) 1995-05-05 1995-05-05 Organic compounds
PCT/EP1996/001841 WO1996034849A1 (fr) 1995-05-05 1996-05-03 Tetralines ayant un substituant phenyle sur le noyau aromatique et utilisation de ces tetralines dans le traitement de l'epilepsie, des accidents cardiovasculaires et des traumatismes du cerveau ou de la moelle epiniere

Publications (3)

Publication Number Publication Date
FI973530A0 FI973530A0 (fi) 1997-08-27
FI973530A7 FI973530A7 (fi) 1997-11-04
FI973530L true FI973530L (fi) 1997-11-04

Family

ID=10774032

Family Applications (1)

Application Number Title Priority Date Filing Date
FI973530A FI973530L (fi) 1995-05-05 1996-05-03 Tetraliineja

Country Status (32)

Country Link
US (1) US6169116B1 (fr)
EP (1) EP0823892B1 (fr)
JP (1) JP3194965B2 (fr)
KR (1) KR100435009B1 (fr)
CN (1) CN1122019C (fr)
AR (1) AR004484A1 (fr)
AT (1) ATE193884T1 (fr)
AU (1) AU706392B2 (fr)
BR (1) BR9608169A (fr)
CA (1) CA2217855C (fr)
CO (1) CO4440486A1 (fr)
CZ (1) CZ292022B6 (fr)
DE (1) DE69608891T2 (fr)
DK (1) DK0823892T3 (fr)
ES (1) ES2148772T3 (fr)
FI (1) FI973530L (fr)
GB (1) GB9509156D0 (fr)
GR (1) GR3033715T3 (fr)
HU (1) HUP9801068A3 (fr)
IL (1) IL118141A (fr)
MX (1) MX9708510A (fr)
NO (1) NO308948B1 (fr)
NZ (1) NZ308471A (fr)
PE (1) PE54797A1 (fr)
PL (1) PL182857B1 (fr)
PT (1) PT823892E (fr)
RU (1) RU2169727C2 (fr)
SK (1) SK282022B6 (fr)
TR (1) TR199701298T1 (fr)
TW (1) TW359667B (fr)
WO (1) WO1996034849A1 (fr)
ZA (1) ZA963540B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1458386B1 (fr) 2001-12-27 2007-04-18 Ortho-McNeil Pharmaceutical, Inc. Arylpyrrole heteroaryle et methanols utilises pour le traitement de troubles du systeme nerveux central
WO2003097586A1 (fr) 2002-05-17 2003-11-27 Janssen Pharmaceutica N.V. Modulateurs de l'uree derives de l'aminotetraline du recepteur vanilloide vr1
WO2005037286A1 (fr) 2003-03-25 2005-04-28 Vasopharm Biotech Gmbh Utilisation de derives de pteridine pour le traitement de l'augmentation de la pression intracranienne et de l'ischemie secondaire
EP1956006A1 (fr) 2007-02-06 2008-08-13 Laboratorios del Dr. Esteve S.A. Dérivés de tétrahydronaphthalène substitués par hétérocycles en tant que ligands de recepteur 5-HT7
EP1975161A1 (fr) * 2007-03-28 2008-10-01 Laboratorios del Dr. Esteve S.A. Dérivés hétérocyclyle-substitué- tétrahydro-naphtalène-amine, leur préparation et utilisation en tant que médicaments
US20100227934A1 (en) * 2007-06-15 2010-09-09 University Of Florida Research Foundation, Inc Therapeutic compounds and methods of use
EP2011786A1 (fr) * 2007-07-05 2009-01-07 Laboratorios del Dr. Esteve S.A. Dérivés d'indanamine, leur préparation et utilisation en tant que médicaments
EP3145906B1 (fr) * 2014-05-19 2023-10-04 Northeastern University Composés de ciblage de récepteur de sérotoninergique
EP4200287A4 (fr) * 2020-08-19 2024-12-18 Northeastern University Modulateurs des récepteurs à la sérotonine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6045179B2 (ja) * 1977-06-08 1985-10-08 フナイ薬品工業株式会社 新規環状アミノアルコ−ル類およびその製造法
EP0257285A3 (fr) 1986-07-28 1989-12-27 Whitby Research Incorporated Procédé et compositions pour réduire la pression intraoculaire des mammifères
DE3718317A1 (de) 1986-12-10 1988-06-16 Bayer Ag Substituierte basische 2-aminotetraline
EP0381902A1 (fr) 1989-01-09 1990-08-16 Merrell Dow Pharmaceuticals Inc. Dérivés de tétraline
JP2931986B2 (ja) 1989-02-17 1999-08-09 武田薬品工業株式会社 アラルキルアミン誘導体
SE8901889D0 (sv) * 1989-05-26 1989-05-26 Astra Ab Novel 8-substituted-2-aminotetralines
EP0640618B1 (fr) * 1993-08-27 1999-10-20 F. Hoffmann-La Roche Ag Dérivés peptidiques de la tétrahydronaphthalène
FR2711139B1 (fr) * 1993-10-15 1995-12-01 Adir Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
BR9608169A (pt) 1999-02-09
DE69608891D1 (de) 2000-07-20
AU706392B2 (en) 1999-06-17
NO975087D0 (no) 1997-11-04
ATE193884T1 (de) 2000-06-15
AU5812996A (en) 1996-11-21
RU2169727C2 (ru) 2001-06-27
CA2217855C (fr) 2008-12-09
FI973530A7 (fi) 1997-11-04
WO1996034849A1 (fr) 1996-11-07
PE54797A1 (es) 1998-01-21
NO975087L (no) 1997-11-04
IL118141A0 (en) 1996-09-12
HUP9801068A3 (en) 2000-02-28
HK1014929A1 (en) 1999-10-08
PL182857B1 (pl) 2002-03-29
SK282022B6 (sk) 2001-10-08
HUP9801068A2 (hu) 1999-05-28
ZA963540B (en) 1997-11-03
EP0823892B1 (fr) 2000-06-14
GB9509156D0 (en) 1995-06-28
KR100435009B1 (ko) 2004-08-16
MX9708510A (es) 1998-03-31
KR19990008301A (ko) 1999-01-25
JP3194965B2 (ja) 2001-08-06
US6169116B1 (en) 2001-01-02
NO308948B1 (no) 2000-11-20
TW359667B (en) 1999-06-01
EP0823892A1 (fr) 1998-02-18
AR004484A1 (es) 1998-12-16
JPH10513479A (ja) 1998-12-22
CN1122019C (zh) 2003-09-24
CZ348697A3 (cs) 1998-02-18
IL118141A (en) 2002-11-10
CZ292022B6 (cs) 2003-07-16
CO4440486A1 (es) 1997-05-07
ES2148772T3 (es) 2000-10-16
GR3033715T3 (en) 2000-10-31
PL323037A1 (en) 1998-03-02
DE69608891T2 (de) 2000-11-16
FI973530A0 (fi) 1997-08-27
PT823892E (pt) 2000-11-30
TR199701298T1 (xx) 1998-02-21
SK148597A3 (en) 1998-10-07
CN1183763A (zh) 1998-06-03
CA2217855A1 (fr) 1996-11-07
NZ308471A (en) 1999-01-28
DK0823892T3 (da) 2000-10-02

Similar Documents

Publication Publication Date Title
DE59602881D1 (de) Sollwertgeber
FI951018A0 (fi) Hoeghastighetsdataoeverfoering i mobiltelesystem
ATA135896A (de) Skibob
FI973530L (fi) Tetraliineja
ATE198470T1 (de) Alkenyl-benzoylguanidine
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
FI1900U1 (fi) Spejningsbraeda foer katter i hoeghus
FI2190U1 (fi) Stoedkonstruktion foer sprutroer i en pappersmaskin/kartongmaskin
FI2204U1 (fi) Lyftmekanism foer en saekerhetskant i en saeng
FI1803U1 (fi) Anordning i saollskopa
FI1872U1 (fi) I dryckesbackar anvaendbart reklammaterial
FI2050U1 (fi) Rullstol foer fastmontering i fordonsgolv
FI952490A0 (fi) Roerningsapparat foer i synnerhet kallroekning i hemhushaoll
FI956200A0 (fi) Avvisarlistarrangemang i hisskorg
FI955358A0 (fi) Aotkomstfoerfarande foer tvaovaegskommunikation i kabeltelevisionssystem
FI954315A0 (fi) Vaendanordning foer i synnerhet kylanordningar foer skivformiga stycken
FI953322A0 (fi) Foerpackningsapparatur foer i staplar frammabart styckegods
FI952415A0 (fi) Faerrkotrollsystem foer vaetskemaengden i en behaollare
BR7500991U (pt) Caríndio
BR7501399U (pt) Ciclonavegador
BR7500437U (pt) Girolight
BR7500703U (pt) Rodopratic
BR7500809U (pt) Tele-negocios
BR7500825U (pt) Chutegol

Legal Events

Date Code Title Description
MA Patent expired